ClinicalTrials.gg
Not yet recruitingNCT07565571SIER-WONEUpdated May 4, 2026

Evaluating a Digital Intervention to Improve Resilience and Reduce Stress in Stanford Populations

An interventional study of Intervention WONE App (full Version) in Resilience, Psychological and Mental Well-being, sponsored by Stanford University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by Stanford University · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
260
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Psychological Well-Being by Stanford University — 5 open to participants now, 7 under way, none of them phase 3. Psychological Well-Being · Stanford University.

Planned enrollment
4th of 11
260 · median 154
Started
2026
with 4 others
No phase
10 of 13
5 open now
Registered
12th of 13
by date

Among the 13 studies in Psychological Well-Being by Stanford University, this one is the 4th largest by planned enrollment of the 11 interventional ones that give a count, is one of 5 that started in 2026, is one of 10 with no phase, and was the 12th registered.

Psychological Well-Being

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

5 of the 13 studies in Psychological Well-Being by Stanford University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Psychological Well-Being by Stanford University, or all of them as a file.
02

Study summary

High-achieving academic and entrepreneurial populations face elevated risks of chronic stress, anxiety, and burnout. These populations often underutilize mental health services due to stigma, time constraints, or accessibility issues. Digital interventions provide an opportunity to deliver evidence-based stress and resilience support at scale.

The WONE (Walking on Earth, Ltd.) platform integrates personalized stress-resilience assessments, behavioral science micro-interventions, and optional wearable data feedback. This project aims to evaluate the feasibility, engagement, and preliminary efficacy of the WONE digital intervention in multiple Stanford-affiliated cohorts.

Read the detailed description

Primary Objective To evaluate whether engagement with the WONE app improves resilience, emotional well-being, and stress management outcomes among Stanford-affiliated adults.

Secondary Objective To evaluate the feasibility of wearable-device integration.

Rationale for Two-Phase Structure This protocol includes two sequential studies.

  1. Phase 1 (Pilot): A single-arm feasibility pilot designed to assess acceptability of the WONE digital intervention, verify that onboarding, survey workflows, and data capture function smoothly, and identify any usability issues before running a randomized trial.
  2. Phase 2 (Randomized Crossover RCT): A fully powered evaluation of the efficacy of WONE, using a 12-week crossover design to compare intervention vs. control periods, followed by a 6-month follow-up to evaluate maintenance of effects.

Phase 1 Objectives (Pilot)

  1. Assess feasibility and acceptability of the WONE digital intervention over 8 weeks.
  2. Evaluate preliminary changes in resilience, emotional well-being, and stress management from baseline to Week 8. Secondary analysis will also explore changes in symptoms related to anxiety and depression.
  3. Describe engagement patterns and examine whether engagement relates to changes in outcomes.
  4. Assess feasibility of wearable integration, including connection rates and data completeness.

Phase 2 Objectives (Randomized Crossover RCT)

  1. Test the efficacy of the WONE intervention compared to a control period using a 12-week crossover design.
  2. Examine changes in resilience, emotional well-being, and stress management across intervention vs. control phases. Secondary analysis will also explore changes in symptoms related to anxiety and depression.
  3. Investigate engagement as a predictor of improvement.
  4. Evaluate maintenance of effects at the 6-month follow-up.
03

Conditions studied

  • Resilience, Psychological
  • Mental Well-being

Keywords

  • resilience
  • entrepreneurs
  • mental well-being
  • stanford
  • WONE
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged between 18 and 65 years with Stanford affiliation
  2. English proficiency with the ability to read, write, and complete surveys in English
  3. Smartphone with internet access
  4. Willingness to complete surveys and app activities
  5. Resides in the US
  6. Stanford affiliation
  7. Wearable device for Phase 1 Pilot Study

Exclusion criteria

Exclusion Criteria:

  1. Severe psychiatric instability, defined as any of the following self-reported on the pre-enrollment screener:

    1. Psychiatric hospitalization for a mental health crisis in the past 12 months.
    2. Current mental health symptoms that significantly impair ability to function in daily life (e.g., unable to work, attend school, or care for basic needs).
  2. No smartphone or unwilling to consent.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
260 participants (estimated)

Study arms

  • Other
    Phase 2: Control (Weeks 1-12) then Intervention (Weeks 13-24)

    Arm A: The control and intervention conditions are delivered via two separate versions of the WONE mobile application: 1. Control WONE app (limited version) - used during control periods 2. Intervention WONE app (full version) - used during intervention periods. At baseline, participants download the Control version. At Week 12, participants receive instructions via email to download the alternate Intervention version. The participants are blinded to the sequence.

    Behavioral: Intervention WONE App (full Version)

  • Other
    Phase 2: Intervention (Weeks 1-12) then Control (Weeks 13-24)

    Arm B: The control and intervention conditions are delivered via two separate versions of the WONE mobile application: 1. Intervention WONE app (full version) - used during intervention periods. 2. Control WONE app (limited version) - used during control periods. At baseline, participants download the Intervention version. At Week 12, participants receive instructions via email to download the alternate Control version. Participants are blinded to the sequence.

    Behavioral: Intervention WONE App (full Version)

  • Other
    Phase 1 (pilot, single arm)

    Participants will download the web application for 8 weeks and asked to complete the WONE assessments and use the app for more than 3 times per week and complete week 4 and 8 endpoints assessments.

    Behavioral: Intervention WONE App (full Version)

Interventions

  • BehavioralIntervention WONE App (full Version)

    The Intervention WONE app (Full version) has the following features: * AI coaching for personalized support * Educational articles * Live sessions * On-demand session recordings * WONE Index assessment and tracking * Wearable device connection (optional) and wearable-derived scores and metrics The control WONE app (limited version) has no above features, only has push notifications for participants to complete assessments.

06

What researchers measure

Primary outcomes

  1. Phase 1: Change in Walking on Earth Index (WONE) Index

    WONE index is a 50-item validated measure of psychosocial resilience, recently validated against the Connor-Davidson Resilience Scale and the Brief Resilience Scale. Higher scores indicate greater resilience and well-being.

    Time frame: Baseline, week 4, week 8

  2. Phase 2: Change in WONE Index

    WONE index is a 50-item validated measure of psychosocial resilience. Higher scores indicate greater resilience and well-being.

    Time frame: Baseline, week 4, week 8, week 12, week 16, week 20, week 24

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — This is a pilot study and early phase study. The plan for sharing individual participant data has not yet been determined. Study team will update after study has completed its enrollment.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for Jun 2027, 13 months later.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 13 months is below that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2026
First posted
May 4, 2026
StartEst.
May 2026
Primary completionEst.
Jun 2027
CompletionEst.
Aug 2027
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07565571
Collaborators
Walking on Earth Ltd.
Responsible party
Alan Ching Yuen Yeung (Professor in Medicine, Stanford University) — Principal investigator
First posted
May 4, 2026
Start date
May 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
May 4, 2026

Study contacts

Chloe Yeung
Contact
cayeung@stanford.edu
6502450094
Alan Yeung, MD
Contact
ayeung@stanford.edu
6507282619
Alan Yeung, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion